BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 8, 2016
View Archived Issues
Syndax Pharmaceuticals and UCB enter exclusive worldwide license agreement for UCB-6352
Read More
Janssen Biotech exercises option within global license agreement with OSE Immunotherapeutics
Read More
Lysogene enrolls first patient in SAMOS study
Read More
First clinical data reported for novel ketolide WCK-4873
Read More
Positive topline results from phase IIb trial of vobarilizumab as monotherapy in RA
Read More
Bayer Healthcare develops Mnk1 inhibitors
Read More
ArmaGen signs collaboration with Rett Syndrome Research Trust
Read More
Forendo Pharma Oy patents 17beta-HSD1 inhibitors
Read More
Akarna Therapeutics discloses farnesoid X receptor agonists
Read More
Takeda Pharmaceutical presents GluN2B receptor inhibitors
Read More
Galderma Pharma divulges chemokine receptor antagonists
Read More
Rugen Holdings Cayman patent reports GluN2B antagonists
Read More
MicuRx Pharmaceuticals introduces antibacterial compounds
Read More
Seres Therapeutics begins phase Ib trial of microbiome therapeutic
Read More
CSI Laboratories launches a novel comprehensive PD-L1 expression assay
Read More
FDA issues complete response letter for Aggrastat in new STEMI indication
Read More
FDA grants fast track designation to idalopirdine
Read More
FDA approves Xolair for children with allergic asthma
Read More
Anti-apoE4 MAb 9D11 prevents beta-amyloid accumulation in vivo
Read More
Ribaxamase approved as generic name for Synthetic Biologics' SYN-004
Read More
Alnylam initiates phase I/II trial of ALN-HBV to treat chronic HBV infection
Read More
FDA places clinical hold on phase II ROCKET trial of JCAR-015 following patient deaths
Read More
TherapeuticsMD submits NDA for Yuvvexy for dyspareunia
Read More
GON4L identified as potential cancer biomarker and therapeutic target
Read More
Pivotal phase III data reported for deutetrabenazine in Huntington's disease
Read More